| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = -$15,217 ) |
| 2024 | 2021 | UNIVERSITY OF TEXAS AT AUSTIN | 110 INNER CAMPUS DR | AUSTIN | TX | 78712 | TRAVIS | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 5 | 1/26/2024 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | -$15,217 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| 2023 | 2021 | THE RAND CORPORATION | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 4 | 5/12/2023 | NON-COMPETING CONTINUATION | $50 |
| 2023 | 2021 | UNIVERSITY OF TEXAS AT AUSTIN | 110 INNER CAMPUS DR | AUSTIN | TX | 78712 | TRAVIS | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 001 | 5 | 5/12/2023 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | -$50 |
|
| Issue Date FY: 2022 ( Subtotal = -$47,833 ) |
| 2022 | 2021 | RAND CORPORATION, THE | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 4 | 5/19/2022 | NON-COMPETING CONTINUATION | -$221,561 |
| 2022 | 2021 | UNIVERSITY OF TEXAS AT AUSTIN | 110 INNER CAMPUS DR | AUSTIN | TX | 78712 | TRAVIS | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 004 | 5 | 6/27/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $147,207 |
| 2022 | 2021 | UNIVERSITY OF TEXAS AT AUSTIN | 110 INNER CAMPUS DR | AUSTIN | TX | 78712 | TRAVIS | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 001 | 5 | 5/20/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $173,728 |
| 2022 | 2021 | RAND CORP | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 003 | 4 | 6/27/2022 | NON-COMPETING CONTINUATION | -$116,205 |
| 2022 | 2020 | RAND CORP | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 002 | 3 | 6/27/2022 | NON-COMPETING CONTINUATION | -$31,002 |
|
| Issue Date FY: 2021 ( Subtotal = $337,766 ) |
| 2021 | 2021 | RAND CORPORATION, THE | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 4 | 6/25/2021 | NON-COMPETING CONTINUATION | $337,766 |
|
| Issue Date FY: 2020 ( Subtotal = $342,256 ) |
| 2020 | 2020 | RAND CORPORATION, THE | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 3 | 6/29/2020 | NON-COMPETING CONTINUATION | $342,256 |
|
| Issue Date FY: 2019 ( Subtotal = $335,972 ) |
| 2019 | 2019 | RAND CORPORATION, THE | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 2 | 7/18/2019 | NON-COMPETING CONTINUATION | $335,972 |
|
| Issue Date FY: 2018 ( Subtotal = $331,832 ) |
| 2018 | 2018 | RAND CORPORATION, THE | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 1 | 9/15/2018 | NEW | $331,832 |
|
|